During the past decade, RPA Sexual Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "RPA Sexual Health" are "HIV" (2 trials) and "STI" (1 trials). Many other conditions were trialed in "RPA Sexual Health" in a lesser frequency.

Most popular intervention types in "RPA Sexual Health" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "TDF/FTC" (1 trials) and "emtricitabine/tenofovir disoproxil fumarate" (1 trials). Other intervention names were less common.

The vast majority of trials in "RPA Sexual Health" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "RPA Sexual Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in RPA Sexual Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RPA Sexual Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".